Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02491333Phase 3Completed
Phase 3, randomised, double-blind trial in polycystic ovary syndrome (PCOS) and insulin resistance (IR) (3 arms), sponsored by The First Affiliated Hospital of Guangzhou Medical University. Primary endpoint: Changes of Homeostatic Model Assessment for Insulin Resistance at 7 months. Started Aug 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02491333.